Page last updated: 2024-08-25

suplatast tosilate and Chronic Lung Injury

suplatast tosilate has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujitaka, K; Fukuhara, K; Hamada, H; Hattori, N; Horimasu, Y; Iwamoto, H; Izumi, Y; Masuda, T; Miyamoto, S; Nakashima, T; Sakamoto, S; Shioya, S; Yamaguchi, K1
Abe, M; Fujitaka, K; Fukuhara, K; Hamada, H; Hattori, N; Iwamoto, H; Kohno, N; Masuda, T; Nakashima, T1

Other Studies

2 other study(ies) available for suplatast tosilate and Chronic Lung Injury

ArticleYear
Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress.
    Free radical biology & medicine, 2019, 05-20, Volume: 136

    Topics: Animals; Arylsulfonates; Lung Injury; Mice; Mice, Inbred C57BL; Oxidative Stress; Radiation Injuries, Experimental; Radiation-Protective Agents; Sulfonium Compounds

2019
Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
    Free radical biology & medicine, 2017, Volume: 106

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arylsulfonates; Asthma; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Deoxyguanosine; DNA Damage; Humans; Hydroxyl Radical; Interleukin-6; Lipid Peroxidation; Lung; Lung Injury; Mice; Oxidative Stress; Reactive Oxygen Species; Sulfonium Compounds; Th2 Cells

2017